Article
Los Angeles--The largest clinical database built on renal cell carcinoma is beginning to yield definitive answers to questions about prognosis and treatment. Analyses of histories of more than 4,000 patients at eight academic medical centers worldwide has already indicated that tumor stage, grade, and performance status have a stronger influence on prognosis than tumor stage alone and that the indications for partial nephrectomy can expand.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.